Načítá se...
Polycythemia vera treatment algorithm 2018
Recently reported mature survival data have confirmed the favorable prognosis in polycythemia vera (PV), with an estimated median survival of 24 years, in patients younger than age 60 years old. Currently available drugs for PV have not been shown to prolong survival or alter the natural history of...
Uloženo v:
| Vydáno v: | Blood Cancer J |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Nature Publishing Group UK
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5802495/ https://ncbi.nlm.nih.gov/pubmed/29321547 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41408-017-0042-7 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|